{"data":{"id":4044,"citation":"Kumar S, Waldo JP, Jaipuri FA, Marcinowicz A, Van Allen C, Adams J, Kesharwani T, Zhang X, Metz R, Oh AJ, Harris SF, Mautino MR.: Discovery of Clinical Candidate (1<i>R<\/i>,4<i>r<\/i>)-4-((<i>R<\/i>)-2-((<i>S<\/i>)-6-Fluoro-5<i>H<\/i>-imidazo[5,1-<i>a<\/i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1. J Med Chem, Volume 62 (14), 2019","title":"Discovery of Clinical Candidate (1<i>R<\/i>,4<i>r<\/i>)-4-((<i>R<\/i>)-2-((<i>S<\/i>)-6-Fluoro-5<i>H<\/i>-imidazo[5,1-<i>a<\/i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1.","doi":"10.1021\/acs.jmedchem.9b00662","doi_url":"https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00662","pmid":"31264862","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31264862\/","year":2019,"journal":"J Med Chem","volume":"62","issue":"14","page":"6705-6733","authors":[{"first_name":"Adams J","last_name":null,"full_name":null},{"first_name":"Harris SF","last_name":null,"full_name":null},{"first_name":"Jaipuri FA","last_name":null,"full_name":null},{"first_name":"Kesharwani T","last_name":null,"full_name":null},{"first_name":"Kumar S","last_name":null,"full_name":null},{"first_name":"Marcinowicz A","last_name":null,"full_name":null},{"first_name":"Mautino MR.","last_name":null,"full_name":null},{"first_name":"Metz R","last_name":null,"full_name":null},{"first_name":"Oh AJ","last_name":null,"full_name":null},{"first_name":"Van Allen C","last_name":null,"full_name":null},{"first_name":"Waldo JP","last_name":null,"full_name":null},{"first_name":"Zhang X","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/4044","landing_page":"https:\/\/molmedb.upol.cz\/publication\/4044","created_at":"2024-05-21T20:14:47.000000Z","updated_at":null}}